COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
-2025 is poised to be a catalyst-rich year with key updates across several programs- -Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in [...]
Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions
11/02/2025
RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that Thrive , a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers [...]
SportGait and Heads Together Health Merge to Form NeuroTech Insights, Transforming Neurofunctional Prehabilitation, Performance, and Recovery
11/02/2025
RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- SportGait, a leading innovator in prehabilitation, performance, and recovery solutions, proudly announces its merger with Branelie Health, Inc., operating as Heads [...]
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
11/02/2025
WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company today announced that the United States Food and Drug [...]
IBA - Information réglementée
11/02/2025
Le 11 février 2025, 18h00 En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de [...]
IBA - Regulated Information
11/02/2025
IBA SA – Section 15 of the transparency act February 11 th 6:00, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to [...]
IBA – Transparency Notification IBA SA
11/02/2025
IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam [...]
IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE IBA SA
11/02/2025
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 11 février 2025, 18h Résumé de la notification [...]
IBA – Transparency Notification
11/02/2025
IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam [...]
IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE
11/02/2025
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 11 février 2025, 18h Résumé de la notification [...]
IBA – Transparency Notification
11/02/2025
IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam [...]
IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE
11/02/2025
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 11 février 2025, 18h Résumé de la notification [...]
Vivoryon Therapeutics N.V. to Host Virtual R&D Update with KOL Speakers on February 18, 2025
11/02/2025
Vivoryon Therapeutics N.V. to Host Virtual R&D Update with KOL Speakers on February 18, 2025 Halle (Saale) / Munich, Germany, February 11, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( [...]
Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline
11/02/2025
Dr. Lee will oversee the clinical development of Lycia’s lead programs, LCA-0061 for IgE-mediated diseases and LCA-0321 for Graves’ disease SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Lycia [...]
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
11/02/2025
MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and OTCPINK: PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics [...]
H.H.C. Group Releases 2024 Client Survey Results, Projects Key Healthcare Cost Trends for 2025
11/02/2025
ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Cepham Introduces Life Phases and Stages Blends For the Next Evolution in Personalized Nutrition
11/02/2025
SOMERSET, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cepham , a leader in nutraceutical innovation, has introduced its Life Phases and Stages Blends (LPAS Blends), a new line of scientifically formulated ingredient blends [...]
Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights
11/02/2025
10-years of translating scientific innovation into accessible clinical solutions HOUSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic laboratory at the forefront of genetic testing, marks [...]
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
11/02/2025
Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201 PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company [...]

Pages